
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
João Tomé‐Carneiro, Mar Larrosa, Antonio González‐Sarrías, et al.
Current Pharmaceutical Design (2013) Vol. 19, Iss. 34, pp. 6064-6093
Open Access | Times Cited: 424
João Tomé‐Carneiro, Mar Larrosa, Antonio González‐Sarrías, et al.
Current Pharmaceutical Design (2013) Vol. 19, Iss. 34, pp. 6064-6093
Open Access | Times Cited: 424
Showing 1-25 of 424 citing articles:
Lipid metabolic reprogramming in cancer cells
Sadia Beloribi‐Djefaflia, Sophie Vasseur, Fabienne Guillaumond
Oncogenesis (2016) Vol. 5, Iss. 1, pp. e189-e189
Open Access | Times Cited: 1225
Sadia Beloribi‐Djefaflia, Sophie Vasseur, Fabienne Guillaumond
Oncogenesis (2016) Vol. 5, Iss. 1, pp. e189-e189
Open Access | Times Cited: 1225
The effects of polyphenols and other bioactives on human health
César G. Fraga, Kevin D. Croft, David O. Kennedy, et al.
Food & Function (2019) Vol. 10, Iss. 2, pp. 514-528
Open Access | Times Cited: 888
César G. Fraga, Kevin D. Croft, David O. Kennedy, et al.
Food & Function (2019) Vol. 10, Iss. 2, pp. 514-528
Open Access | Times Cited: 888
The therapeutic potential of resveratrol: a review of clinical trials
Adi Y. Berman, Rachel A. Motechin, Maia Y. Wiesenfeld, et al.
npj Precision Oncology (2017) Vol. 1, Iss. 1
Open Access | Times Cited: 730
Adi Y. Berman, Rachel A. Motechin, Maia Y. Wiesenfeld, et al.
npj Precision Oncology (2017) Vol. 1, Iss. 1
Open Access | Times Cited: 730
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Michael S. Bonkowski, David Sinclair
Nature Reviews Molecular Cell Biology (2016) Vol. 17, Iss. 11, pp. 679-690
Open Access | Times Cited: 704
Michael S. Bonkowski, David Sinclair
Nature Reviews Molecular Cell Biology (2016) Vol. 17, Iss. 11, pp. 679-690
Open Access | Times Cited: 704
The Role of Resveratrol in Cancer Therapy
Jeong‐Hyeon Ko, Gautam Sethi, Jae‐Young Um, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 12, pp. 2589-2589
Open Access | Times Cited: 651
Jeong‐Hyeon Ko, Gautam Sethi, Jae‐Young Um, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 12, pp. 2589-2589
Open Access | Times Cited: 651
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft, et al.
Neurology (2015) Vol. 85, Iss. 16, pp. 1383-1391
Open Access | Times Cited: 599
Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft, et al.
Neurology (2015) Vol. 85, Iss. 16, pp. 1383-1391
Open Access | Times Cited: 599
Bioactivity of dietary polyphenols: The role of metabolites
Simon Vlad Luca, Irina Macovei, Alexandra Bujor, et al.
Critical Reviews in Food Science and Nutrition (2019) Vol. 60, Iss. 4, pp. 626-659
Closed Access | Times Cited: 554
Simon Vlad Luca, Irina Macovei, Alexandra Bujor, et al.
Critical Reviews in Food Science and Nutrition (2019) Vol. 60, Iss. 4, pp. 626-659
Closed Access | Times Cited: 554
The gut microbiota: A key factor in the therapeutic effects of (poly)phenols
Juan Carlos Espı́n, Antonio González‐Sarrías, Francisco A. Tómas‐Barberán
Biochemical Pharmacology (2017) Vol. 139, pp. 82-93
Closed Access | Times Cited: 508
Juan Carlos Espı́n, Antonio González‐Sarrías, Francisco A. Tómas‐Barberán
Biochemical Pharmacology (2017) Vol. 139, pp. 82-93
Closed Access | Times Cited: 508
Potential Adverse Effects of Resveratrol: A Literature Review
Abdullah Shaito, Anna Maria Posadino, Nadin Younes, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2084-2084
Open Access | Times Cited: 496
Abdullah Shaito, Anna Maria Posadino, Nadin Younes, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2084-2084
Open Access | Times Cited: 496
Resveratrol and cancer: focus on in vivo evidence
Lindsay G. Carter, John A. D’Orazio, Kevin J. Pearson
Endocrine Related Cancer (2014) Vol. 21, Iss. 3, pp. R209-R225
Open Access | Times Cited: 481
Lindsay G. Carter, John A. D’Orazio, Kevin J. Pearson
Endocrine Related Cancer (2014) Vol. 21, Iss. 3, pp. R209-R225
Open Access | Times Cited: 481
Targeting vascular (endothelial) dysfunction
Andreas Daiber, Sebastian Steven, Alina Weber, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 12, pp. 1591-1619
Open Access | Times Cited: 446
Andreas Daiber, Sebastian Steven, Alina Weber, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 12, pp. 1591-1619
Open Access | Times Cited: 446
Health benefits of resveratrol: Evidence from clinical studies
Akhand Pratap Singh, R. P. Singh, Sumit Singh Verma, et al.
Medicinal Research Reviews (2019) Vol. 39, Iss. 5, pp. 1851-1891
Closed Access | Times Cited: 415
Akhand Pratap Singh, R. P. Singh, Sumit Singh Verma, et al.
Medicinal Research Reviews (2019) Vol. 39, Iss. 5, pp. 1851-1891
Closed Access | Times Cited: 415
Urolithins, the rescue of “old” metabolites to understand a “new” concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status
Francisco A. Tómas‐Barberán, Antonio González‐Sarrías, Rocío Garcı́a-Villalba, et al.
Molecular Nutrition & Food Research (2016) Vol. 61, Iss. 1
Closed Access | Times Cited: 396
Francisco A. Tómas‐Barberán, Antonio González‐Sarrías, Rocío Garcı́a-Villalba, et al.
Molecular Nutrition & Food Research (2016) Vol. 61, Iss. 1
Closed Access | Times Cited: 396
Resveratrol and Cardiovascular Diseases
Dominique Bonnefont–Rousselot
Nutrients (2016) Vol. 8, Iss. 5, pp. 250-250
Open Access | Times Cited: 380
Dominique Bonnefont–Rousselot
Nutrients (2016) Vol. 8, Iss. 5, pp. 250-250
Open Access | Times Cited: 380
Antibacterial and antifungal properties of resveratrol
Martin Vestergaard, Hanne Ingmer
International Journal of Antimicrobial Agents (2019) Vol. 53, Iss. 6, pp. 716-723
Open Access | Times Cited: 378
Martin Vestergaard, Hanne Ingmer
International Journal of Antimicrobial Agents (2019) Vol. 53, Iss. 6, pp. 716-723
Open Access | Times Cited: 378
One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease
João Tomé‐Carneiro, Mar Larrosa, María J. Yáñez‐Gascón, et al.
Pharmacological Research (2013) Vol. 72, pp. 69-82
Closed Access | Times Cited: 357
João Tomé‐Carneiro, Mar Larrosa, María J. Yáñez‐Gascón, et al.
Pharmacological Research (2013) Vol. 72, pp. 69-82
Closed Access | Times Cited: 357
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
Fabiana Andréa Moura, Kívia Queiroz de Andrade, Juliana Célia Farias dos Santos, et al.
Redox Biology (2015) Vol. 6, pp. 617-639
Open Access | Times Cited: 342
Fabiana Andréa Moura, Kívia Queiroz de Andrade, Juliana Célia Farias dos Santos, et al.
Redox Biology (2015) Vol. 6, pp. 617-639
Open Access | Times Cited: 342
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
Beshay N. Zordoky, Ian M. Robertson, Jason R.B. Dyck
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1852, Iss. 6, pp. 1155-1177
Open Access | Times Cited: 310
Beshay N. Zordoky, Ian M. Robertson, Jason R.B. Dyck
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1852, Iss. 6, pp. 1155-1177
Open Access | Times Cited: 310
Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?
Sabine Weiskirchen, Ralf Weiskirchen
Advances in Nutrition (2016) Vol. 7, Iss. 4, pp. 706-718
Open Access | Times Cited: 277
Sabine Weiskirchen, Ralf Weiskirchen
Advances in Nutrition (2016) Vol. 7, Iss. 4, pp. 706-718
Open Access | Times Cited: 277
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Veronique Chachay, Graeme A. Macdonald, Jennifer Martin, et al.
Clinical Gastroenterology and Hepatology (2014) Vol. 12, Iss. 12, pp. 2092-2103.e6
Closed Access | Times Cited: 270
Veronique Chachay, Graeme A. Macdonald, Jennifer Martin, et al.
Clinical Gastroenterology and Hepatology (2014) Vol. 12, Iss. 12, pp. 2092-2103.e6
Closed Access | Times Cited: 270
Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis
Hala Gali‐Muhtasib, Raed Hmadi, Mike Kareh, et al.
APOPTOSIS (2015) Vol. 20, Iss. 12, pp. 1531-1562
Closed Access | Times Cited: 265
Hala Gali‐Muhtasib, Raed Hmadi, Mike Kareh, et al.
APOPTOSIS (2015) Vol. 20, Iss. 12, pp. 1531-1562
Closed Access | Times Cited: 265
Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity
Douglas R. Seals, Jamie N. Justice, Thomas J. LaRocca
The Journal of Physiology (2015) Vol. 594, Iss. 8, pp. 2001-2024
Open Access | Times Cited: 254
Douglas R. Seals, Jamie N. Justice, Thomas J. LaRocca
The Journal of Physiology (2015) Vol. 594, Iss. 8, pp. 2001-2024
Open Access | Times Cited: 254
Resveratrol and cancer: Challenges for clinical translation
Chandra K. Singh, Mary A. Ndiaye, Nihal Ahmad
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1852, Iss. 6, pp. 1178-1185
Open Access | Times Cited: 250
Chandra K. Singh, Mary A. Ndiaye, Nihal Ahmad
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1852, Iss. 6, pp. 1178-1185
Open Access | Times Cited: 250
Resveratrol and Its Human Metabolites—Effects on Metabolic Health and Obesity
Margherita Springer, Sofia Moco
Nutrients (2019) Vol. 11, Iss. 1, pp. 143-143
Open Access | Times Cited: 241
Margherita Springer, Sofia Moco
Nutrients (2019) Vol. 11, Iss. 1, pp. 143-143
Open Access | Times Cited: 241
Interaction of dietary polyphenols and gut microbiota: Microbial metabolism of polyphenols, influence on the gut microbiota, and implications on host health
Gizem Çatalkaya, Koen Venema, Luigi Lucini, et al.
Food Frontiers (2020) Vol. 1, Iss. 2, pp. 109-133
Open Access | Times Cited: 229
Gizem Çatalkaya, Koen Venema, Luigi Lucini, et al.
Food Frontiers (2020) Vol. 1, Iss. 2, pp. 109-133
Open Access | Times Cited: 229